24.7 C
Singapore
Saturday, December 10, 2022
Ads

JAPAN’S SHIONOGI DEVELOPS COVID-19 PILL THAT PROMISES RAPID CLEARANCE OF VIRUS

Japanese pharmaceutical company Shionogi said Sunday that an experimental treatment from the company showed it could quickly clear the virus that causes COVID-19.

Advertisements

Shionogi said in a statement that the development of the new drug, labelled S-217622, ​​”demonstrates rapid clearance of the infectious new coronavirus,” citing Phase 2b results of the drug’s second/third clinical trial.

Under Evaluation

The company has global expectations for the antiviral tablet, which is currently under evaluation by Japanese regulators.

The results of the Covid-19 disease study, released Sunday, showed “no significant difference in the total score of 12 COVID-19 symptoms among the treatment groups,” although the drug’s composite score improved five “breathing and fever” symptoms.

The drugmaker said in March that it would launch a global Phase 3 clinical trial of the drug with U.S. government support.

Advertisements
- Advertisement -
- Advertisement -
Latest News

WOMAN IN HER 30S HAS A CRUSH ON 16 Y.O XIAO DIDI PART TIMER AT HER WORKPLACE

"I'm a woman in my 30s, and recently I came to know this 16 y.o guy who finished his...
- Advertisement -